Mail-in HPV Screening Program in NJ
ConditionCervical Cancer Screening
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-75
SponsorRutgers, The State University of New Jersey
About this trial
The purpose of this study is to help people who have missed their regular cervical cancer screening. The investigators are evaluating whether mailing an HPV self-sampling kit to participant home makes it easier and more convenient for people to get screened for cervical cancer. This study will also help to understand if people find this process acceptable and whether it is an effective way to improve screening rates.
Eligibility criteria
Qualifiers
Women, transgender men, and nonbinary individuals aged 30 to 75 who have a cervix.
No history of hysterectomy or cervical cancer.
No documented cervical cancer screening within guideline-recommended intervals: specifically, no Pap test in the past 3.5 years, no Pap/HPV co-test in the past 5.5 years, and no standalone HPV test results in the past 5.5 years. (A 6-month grace period is included to allow time for response to usual care outreach.)
At least two visits to University Hospital ambulatory care over the past five years, ensuring opportunity for follow-up and continuity of care.
Disqualifiers
History of cervical dysplasia within the past 3.5 years, reflecting those likely under active surveillance or treatment protocols.
Currently pregnant, due to differing screening recommendations and clinical considerations.
Prior or current diagnosis of cervical cancer or ongoing treatment for cervical neoplasia.
Physical, cognitive, or functional limitations that would preclude use of the mailed self-sampling kit without assistance. Examples include severe arthritis or significant impairment affecting self-collection capability.
Trial design
Treatments tested in this trial
- BD Onclarity HPV test
- Standard Pap Smear
Treatment groups
200 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov